Healthcare & MedTech
Clinical AI that a clinician signs before it acts.
Large clinical-ops opportunity, longer procurement cycles, and a liability line most firms won't touch. We serve payer operations, provider systems, and MedTech device companies, including a hardware-plus-software due diligence capability no software-only consultant can offer.
Use Cases
Eight use cases, from clinical ops to the device layer.
| Use case | Technique | Value delivered |
|---|---|---|
| Clinical documentation automation | Full fine-tune on SOAP notes | 60–70% less documentation time |
| Discharge summary generation | QLoRA on EHR records | Standardised, audit-ready summaries in minutes |
| Prior authorisation processing | RAG on payer policy docs | 80% faster PA turnaround |
| Medical coding (ICD-10 / CPT) | Full fine-tune on clinical docs | 90%+ auto-coding accuracy |
| Diagnostic decision support | Full fine-tune on clinical literature | Triage-level diagnostic confidence at point of care |
| Radiology report drafting | Fine-tune on radiologist corpus | Draft report in seconds; radiologist edits and signs |
| Clinical trial matching | RAG on eligibility criteria | Faster eligible-patient identification |
| MedTech DD, BLE hardware layer | Operator-level firmware assessment | Uncovers device risks software-only consultants miss |
The Boundary
Clinical AI: full vs. supervised delivery, a published protocol.
The liability cliff isn't clinical AI itself. It's clinical AI autonomy. A supervised POC that a clinician reviews before acting is fundamentally different from a model that makes autonomous treatment decisions. Supervised delivery captures the revenue without the catastrophic-risk scenario.
Full delivery
Banking, retail, enterprise SaaS, non-clinical healthcare operations, PE ops. Production code, model fine-tuning, deployment, no restrictions.
- Standard SOW and IP Firewall
- Full implementation team
Safeguarded trial delivery only
Sandbox / POC / validation environments. Human Review clause mandatory in every SOW. Clinical Governance Acknowledgement (CGA) required. PHI stays in your tenant, always.
- We review; your clinical team validates
- Never autonomous; a clinician is always in the decision loop
FAQ
Common questions about AI for Healthcare & MedTech.
What healthcare and MedTech use cases does Nyveon.AI build?
Eight patterns spanning clinical documentation, discharge summaries, prior authorization, medical coding, diagnostic decision support, radiology report drafting, clinical trial matching, and MedTech hardware-layer due diligence.
Does a clinician always review the AI's output?
Yes. Clinical AI is supervised delivery only, with a mandatory human review clause and a Clinical Governance Acknowledgement in every SOW, so a clinician is always in the decision loop.
How much time does clinical documentation automation save?
60–70% less documentation time, based on a full fine-tune on SOAP notes.
What makes Nyveon.AI's MedTech due diligence different?
It assesses the BLE/hardware layer alongside the software/cloud layer in one engagement, where most consultants only cover one side.